Publicaciones (23) Publicaciones de ROBERTO PALACIOS RAMIREZ

2023

  1. Benefits of the Non-Steroidal Mineralocorticoid Receptor Antagonist Finerenone in Metabolic Syndrome-Related Heart Failure with Preserved Ejection Fraction

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

  2. Involvement of Bcl-2 Family Proteins in Tetraploidization-Related Senescence

    International Journal of Molecular Sciences, Vol. 24, Núm. 7

  3. Multiomics insights on the onset, progression, and metastatic evolution of breast cancer

    Frontiers in Oncology, Vol. 13

  4. TiO2 Nanospikes Micro-Areas on Rutile Single Crystal Surfaces Determine Arrangements of Rat Aortic Vascular Smooth Muscle Cells

    Proceedings of the IEEE Conference on Nanotechnology

2022

  1. Biglycan Is a Novel Mineralocorticoid Receptor Target Involved in Aldosterone/Salt-Induced Glomerular Injury

    International Journal of Molecular Sciences, Vol. 23, Núm. 12

  2. Mineralocorticoid Receptor Antagonism Prevents the Synergistic Effect of Metabolic Challenge and Chronic Kidney Disease on Renal Fibrosis and Inflammation in Mice

    Frontiers in Physiology, Vol. 13

2020

  1. Cutaneous Wound Healing in Diabetic Mice Is Improved by Topical Mineralocorticoid Receptor Blockade

    Journal of Investigative Dermatology, Vol. 140, Núm. 1, pp. 223-234.e7

2019

  1. Egg White Hydrolysate: A new putative agent to prevent vascular dysfunction in rats following long-term exposure to aluminum

    Food and Chemical Toxicology, Vol. 133

  2. Egg white hydrolysates improve vascular damage in obese Zucker rats by its antioxidant properties

    Journal of Food Biochemistry, Vol. 43, Núm. 12

  3. MR (Mineralocorticoid Receptor) Induces Adipose Tissue Senescence and Mitochondrial Dysfunction Leading to Vascular Dysfunction in Obesity

    Hypertension, Vol. 73, Núm. 2, pp. 458-468

  4. Pioglitazone Modulates the Vascular Contractility in Hypertension by Interference with ET-1 Pathway

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Mitochondrial oxidative stress in obesity: Role of the mineralocorticoid receptor

    Journal of Endocrinology, Vol. 238, Núm. 3, pp. R143-R159

  2. NADPH Oxidase 5 Is a pro-contractile nox isoform and a point of cross-talk for calcium and redox signaling-implications in vascular function

    Journal of the American Heart Association, Vol. 7, Núm. 12

2017

  1. Aluminum exposure at human dietary levels promotes vascular dysfunction and increases blood pressure in rats: A concerted action of NAD(P)H oxidase and COX-2

    Toxicology, Vol. 390, pp. 10-21

2016

  1. Role of COX-2-derived PGE2 on vascular stiffness and function in hypertension

    British Journal of Pharmacology, Vol. 173, Núm. 9, pp. 1541-1555

  2. Spironolactone prevents endothelial nitric oxide synthase uncoupling and vascular dysfunction induced by β-adrenergic overstimulation

    Hypertension, Vol. 68, Núm. 3, pp. 726-735

2015

  1. Cholesteryl ester-transfer protein inhibitors stimulate aldosterone biosynthesis in adipocytes through nox-dependent processes

    Journal of Pharmacology and Experimental Therapeutics, Vol. 353, Núm. 1, pp. 27-34

  2. Toll-like receptor 4 contributes to vascular remodelling and endothelial dysfunction in angiotensin II-induced hypertension

    British Journal of Pharmacology, Vol. 172, Núm. 12, pp. 3159-3176

2014

  1. Pioglitazone reduces angiotensin II-induced COX-2 expression through inhibition of ROS production and ET-1 transcription in vascular cells from spontaneously hypertensive rats

    American Journal of Physiology - Heart and Circulatory Physiology, Vol. 306, Núm. 11

  2. Toll-like receptor 4 upregulation by angiotensin II contributes to hypertension and vascular dysfunction through reactive oxygen species production

    PLoS ONE, Vol. 9, Núm. 8